Catalyst Wire Dossier Catalyst Wire Dossier

Pascoflair 425 mg

· Pascoe Pharmazeutische Praeparate GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pascoflair 425 mg, covering 2010-05-17 to 2010-05-17. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacological Effects of Neurapas® Balance and Pascoflair® 425 mg on Brain Activity in Healthy Volunteers [Phase 1]

See pricing